Evidence map›Paper›PMID 36712661›Full record

ArticleFrontiers in pharmacology2022

Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO-positive acute myeloid leukemia.

Yang Xi, Li Chenglong, Zhang Rong, Wang Wen, Wang Yu, Chen Jiao, Huang Juan, Che Feifei, Xiao Rong, Jiang Tao and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yang XiSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Li ChenglongSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Zhang RongSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Wang WenSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Wang YuSichuan Provincial People's Hospital (Medical Group), Dongli Hospital, Chengdu, China.
Chen JiaoSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Huang JuanSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Che FeifeiSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Xiao RongSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Jiang TaoSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Li HuiSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Huang XiaobingSichuan Provincial People's Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
University of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3-drug combinationAML1-ETOchidamidepost-transplantationrelapse

Identifiers

PMID36712661
PMCPMC9880285
OpenAlexW4315797528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.